Gentry Private Wealth’s AbbVie ABBV Stock Holding History

Gentry Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$487K	Sell	1,936 -43	-2%	-$9.25K	0.25%	50
2026 Q1	$430K	Sell	1,979 -203	-9%	-$45K	0.26%	59
2025 Q4	$499K	Sell	2,182 -406	-16%	-$92.5K	0.31%	48
2025 Q3	$599K	Buy	2,588 +60	+2%	+$12.2K	0.42%	37
2025 Q2	$469K	Buy	2,528 +47	+2%	+$8.73K	0.36%	51
2025 Q1	$520K	Buy	+2,481	New	+$482K	0.43%	45
2024 Q4	–	Sell	-2,142	Closed	-$423K	–	35
2024 Q3	$423K	Sell	2,142 -97	-4%	-$18.1K	0.35%	52
2024 Q2	$384K	Buy	+2,239	New	+$371K	0.34%	51

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gentry Private Wealth's ABBV Position: Q2 2026 in Review

Gentry Private Wealth reduced its AbbVie (ABBV) stake by 2.2% in Q2 2026, selling an estimated $9.25K and leaving 1,936 shares worth $487K. The position accounts for 0.25% of the portfolio, ranked #50.

Gentry Private Wealth first reported a position in ABBV in Q2 2024 and has held it in 8 quarters since. The position peaked at $599K in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Gentry Private Wealth held 1,936 shares of AbbVie worth $487K as of Q2 2026.
Gentry Private Wealth sold 43 AbbVie shares in Q2 2026, an estimated $9.25K.
AbbVie made up 0.25% of Gentry Private Wealth's portfolio in Q2 2026, its #50 holding.
Gentry Private Wealth first reported a position in AbbVie in Q2 2024 and has held it in 8 quarters since.
Gentry Private Wealth's AbbVie position peaked at $599K in Q3 2025.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gentry Private Wealth's 13F filing for Q2 2026, filed 5 Aug 2026.